Single-cell Landscape of Malignant Transition: Unraveling Cancer Cell-of-Origin and Heterogeneous Tissue Microenvironment
Author:
Luo Ruihan1ORCID, Liu Jiajia2, Wen Jianguo3, Zhou Xiaobo3
Affiliation:
1. ruihan.luo@uth.tmc.edu 2. The University of Texas Health Science Center at Houston 3. School of Biomedical Informatics, The University of Texas Health Science Center at Houston
Abstract
Abstract
Understanding disease progression and sophisticated tumor ecosystems is imperative for investigating tumorigenesis mechanisms and developing novel prevention strategies. Here, we dissected heterogeneous microenvironments during malignant transitions by leveraging data from 1396 samples spanning 13 major tissues. Within transitional stem-like subpopulations highly enriched in precancers and cancers, we identified 30 recurring cellular states strongly linked to malignancy, including hypoxia and epithelial senescence, revealing a high degree of plasticity in epithelial stem cells. By characterizing dynamics in stem-cell crosstalk with the microenvironment along the pseudotime axis, we found differential roles of ANXA1 at different stages of tumor development. In precancerous stages, reduced ANXA1 levels promoted monocyte differentiation toward M1 macrophages and inflammatory responses, whereas during malignant progression, upregulated ANXA1 fostered M2 macrophage polarization and cancer-associated fibroblast transformation by increasing TGF-β production. Our spatiotemporal analysis further provided insights into mechanisms responsible for immunosuppression and a potential target to control evolution of precancer and mitigate the risk for cancer development.
Publisher
Research Square Platform LLC
Reference73 articles.
1. Pan-cancer analysis of whole genomes;ConsortiumP.-C.A.o.W ITG;Nature,2020 2. Widschwendter, M., Burnell, M., Fraser, L., Rosenthal, A.N., Philpott, S., Reisel, D., Dubeau, L., Cline, M., Pan, Y., Yi, P.C., et al. (2015). Osteoprotegerin (OPG), The Endogenous Inhibitor of Receptor Activator of NF-kappaB Ligand (RANKL), is Dysregulated in BRCA Mutation Carriers. EBioMedicine 2, 1331–1339. 10.1016/j.ebiom.2015.08.037. 3. Mariz, F.C., Bender, N., Anantharaman, D., Basu, P., Bhatla, N., Pillai, M.R., Prabhu, P.R., Sankaranarayanan, R., Eriksson, T., Pawlita, M., et al. (2020). Peak neutralizing and cross-neutralizing antibody levels to human papillomavirus types 6/16/18/31/33/45/52/58 induced by bivalent and quadrivalent HPV vaccines. NPJ Vaccines 5, 14. 10.1038/s41541-020-0165-x. 4. Influenza virus infection elicits protective antibodies and T cells specific for host cell antigens also expressed as tumor-associated antigens: a new view of cancer immunosurveillance;Iheagwara UK;Cancer Immunol Res,2014 5. Mitochondrial C150T polymorphism increases the risk of cervical cancer and HPV infection;Zhai K;Mitochondrion,2011
|
|